Design Therapeutics, Inc. DSGN
9.67 USD -0.96 (-9.03%)
At closeNov 5, 2026, 4:01 PM EST
9.67 0.00 0.00%
After hours · Nov 5, 4:01 PM ET
9.62 Day range 10.86
6.55 52-week range 15.94
- YTD
- +3.09%
- 1 year
- +47.63%
Financial health
Altman Z-Score
23.15 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -7.7×
FY 2019 5y median -7.7× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 2.5×
FY 2019 5y median 1.7× FY 2025
P/FCF -9.9×
FY 2019 5y median -9.9× FY 2025
EV/EBITDA -7.6×
FY 2019 5y median -7.6× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -10.1%
FY 2019 5y median -10.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -32.8%
FY 2019 5y median -20.5% FY 2025
ROIC -37.1%
FY 2019 5y median -25.5% FY 2025
ROA -30.9%
FY 2019 5y median -19.7% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -27.4%
FY 2019 FY 2025
EPS (diluted) -38.6%
FY 2019 FY 2025
Free Cash Flow -25.6%
FY 2019 FY 2025
Financial Health
Current Ratio 17.1×
FY 2019 5y median 29.6× FY 2025
Quick Ratio 17.1×
FY 2019 5y median 29.6× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.2×
FY 2019 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31